Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Auction Technology Group (ATG) by Oliver Rodzianko in The Motley Fool
- Buy Agronomics Limited (ANIC) by Sumayya Mansoor in The Motley Fool
- Buy Rolls-Royce Holdings (RR.) by Jefferies
- Avoid Pod Point Group Holdings (PODP) by Steve Moore in ShareProphets
- Buy Tharisa (DI) (THS) by Hot Stock Rockets in ShareProphets
- Avoid Cyanconnode Holdings (CYAN) by Steve Moore in ShareProphets
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Avoid Zenova Group (ZED) by Steve Moore in ShareProphets
- Hold Team17 Group (TM17) by Jefferies
- Hold BP (BP.) by Mark David Hartley in The Motley Fool
- Buy Intertek Group (ITRK) by Redburn Partners
- Buy IQE (IQE) by Numis
- Hold 888 Holdings (DI) (888) by Numis
- Buy Oxford Metrics (OMG) by Numis
- Buy Hunting (HTG) by Kepler Cheuvreux
- Add Man Group (EMG) by Numis
- Buy NATWEST GROUP (NWG) by Peel Hunt
- Overweight VinaCapital Vietnam Opportunity Fund Ltd. (VOF) by Barclays
- Hold Lloyds Banking Group (LLOY) by Peel Hunt
- Overweight Victrex plc (VCT) by Barclays
Valirx (VAL) Share Price
Health Care Sector
NOTE: This is based on 6 open tips for Valirx (VAL)
| Latest Bid : 3.40p | Latest Ask : 3.50p |
| High Today : 3.50p | Low Today : 3.40p |
| This Years High : 14.12p | This Years Low : 3.40p |
| Volume : 1,543,329 | MKT Cap : £4.55M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Valirx (VAL) Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.Valirx (VAL) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |
Valirx (VAL) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 3.40p | Latest Ask : 3.50p |
| High Today : 3.50p | Low Today : 3.40p |
| This Years High : 14.12p | This Years Low : 3.40p |
| Volume : 1,543,329 | MKT Cap : £4.55M |
Valirx Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Valirx Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |